Elite Health Q3 10-Q: Going-Concern Doubt, $4.3M Nine-Month Loss, $233K Cyber Loss
EHSI sits 82% above its 52-week low of $0.41 on light trading volume (0.2× avg).
Summary
Elite Health's Q3 10-Q discloses substantial doubt about its ability to continue as a going concern, a $4.3 million nine-month net loss, a new material weakness in controls and a $233,000 cyber fraud loss, alongside the board's authorization to pursue strategic alternatives including a sale or merger.
Key Events · Earnings and Guidance · EHSI
-
Going-Concern Doubt Disclosed
At September 30, 2026 the company had $740,000 of cash, working capital of $136,000 and an accumulated deficit of $16,561,000, with no line of credit or other readily available capital — factors that raised substantial doubt about its ability to continue as a going concern.
-
Nine-Month Loss Widens to $4.3M
Net loss was $4,312,000 for the nine months ended September 30, 2026 versus $2,026,000 a year earlier; Q3 alone lost $1,486,000 versus $1,161,000. Revenue of $3,983,000 produced gross profit of only $414,000 against $4,511,000 of SG&A.
-
Board Weighs Sale or Merger
The board authorized management to pursue strategic alternatives including equity or debt capital, selling operating businesses, a merger or a disposition of all assets. No timetable has been set and there is no assurance any transaction will be completed.
-
Material Weakness and $233K Cyber Loss
Management identified a material weakness in internal control over financial reporting tied to vendor information change verification, and recognized a $233,000 loss from a business email compromise; no insurance recovery was recorded because the claim is still pending.
Analysis · EHSI · Industrial Applications And Services
Management has raised substantial doubt about Elite Health's ability to continue as a going concern at September 30, 2026, with only $740,000 of cash against a $4,312,000 nine-month operating loss and no line of credit. The board's response is to authorize a review of strategic alternatives that explicitly includes a merger or a sale of all assets, so the equity now hinges on a financing or transaction rather than on operations. Layered on top are a newly disclosed material weakness in internal controls and a $233,000 business email compromise loss with no insurance recovery booked yet. Revenue of $1,276,000 in the quarter is real progress versus zero a year ago, but gross profit of $129,000 does not come close to covering $1,386,000 of SG&A.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, EHSI was trading at $0.75 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $21.3M. The 52-week trading range was $0.41 to $1.94. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.